CHRONIC STABLE ILLNESS
Clinical trials for CHRONIC STABLE ILLNESS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC STABLE ILLNESS trials appear
Sign up with your email to follow new studies for CHRONIC STABLE ILLNESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early safety check for COVID antibody cocktail
Prevention CompletedThis early-stage study tested the safety of a combination of two lab-made antibodies (casirivimab+imdevimab) against COVID-19. It involved 45 healthy or medically stable adult volunteers who received the antibodies either as an injection under the skin or through an IV drip. The …
Matched conditions: CHRONIC STABLE ILLNESS
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Prevention
Last updated Mar 06, 2026 15:38 UTC
-
Scientists test if antibody drug interferes with COVID vaccine
Knowledge-focused CompletedThis study aimed to understand if giving a COVID-19 antibody treatment (casirivimab+imdevimab) affects the body's immune response to the Moderna mRNA-1273 vaccine. Researchers enrolled 295 healthy adults to receive the vaccine at different times after the antibody treatment. The …
Matched conditions: CHRONIC STABLE ILLNESS
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC